• The recently released WHO Proposed Addendum to Who TRS 987 Annex 4 – Guidelines on the quality, safety and efficacy of biotherapeutic protein products prepared by recombinant DNA technologies included as a reference an article developed during an AHF sponsored consensus conference: Recommendations for the Regulation of Biosimilars and their Implementation in Latin America. The article was originally published in the GaBI Journal.
  • Break Dengue is calling on citizens around the world to voice their concern about the growing social burden that represents dengue fever and help make it a public health priority. As global and regional health leaders meet to address urgent climate, health, and security issues threatening the world’s population, the Dengue Tribe campaign aims to collect the faces and voices of individuals and communities impacted by the disease to show these leaders it is time to take global collaborative actions to control dengue.
  • Americas Health Foundation representatives participated in the 2015 CONGRESO LATINOAMERICANO DE INFECTOLOGIA PEDIATRICA – SLIPE held in San Juan, Puerto Rico in June.
  • In July 2015, AHF convened a consensus conference in Panama City to address “Multiple Sclerosis in Central America and the Caribbean: Treatment and Care Recommendations.”  Click here to read more.      
  • On August 5th and 6th, the Americas Health Foundation participated in the Fifth Latin American Forum on Biosimilars (FLAB 2015), and the sixth Brazilian Forum on Biosimilars in Brasília, Brazil.
  • Americas Health Foundation, in partnership with Break Dengue, announces the winners of the 2015 Latin American Prizes for Dengue Initiatives.  Congratulations to the following winners:
  • The Americas Health Foundation was a proud sponsor of the Florida International University 5th International Conference on Global Health. The Global Health Consortium was held in Miami May 20-22, 2015.
  • From Tuesday, May 19 – Wednesday, May 20, 2015 AHF, in partnership with the Latin American Society of Pediatric Infectious Disease (SLIPE) and the FIU Global Health Consortium, convened a Dengue Workshop in Miami inviting members of the Dengue Task Force, dengue KOLs and representatives from the Expanded Program on Immunization (EPI) from a number of dengue-endemic Latin American countries. The purpose of this workshop was to discuss dengue vaccination policy and implementation of vaccination programs in the Region. The Dengue Workshop was chaired by Dr.